Brought to you by 
Corixa completes $42.7mm private placement
13 Oct 2011
Executive Summary
Immunotherapeutics developer Corixa netted approximately $42.7mm through the private placement of 7.3mm common shares at $6.13 apiece (a slight discount to the market average). It also issued 1.2mm 5-year warrants to purchase additional shares at an exercise price of $6.13. The placement was led by InterWest Partners, and included BankAmerica Ventures, Frazier Healthcare Ventures, Hambrecht & Quist Capital Management, KBL Healthcare Ventures, Oxford Bioscience Partners, and Sutter Hill Ventures.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
- Vaccines
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Corixa completes $42.7mm private placement
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice